CP
MRK icon

Cumberland Partners’s Merck MRK Stock Holding History

Cumberland Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-93,360
Closed -$7.66M – 177
2022
Q1 		$7.66M Sell
93,360
-13,805
-13% -$1.09M 0.58% 47
2021
Q4 		$8.21M Sell
107,165
-10,220
-9% -$814K 0.58% 43
2021
Q3 		$8.82M Sell
117,385
-635
-0.5% -$48.3K 0.72% 34
2021
Q2 		$9.18M Sell
118,020
-6,540
-5% -$486K 0.72% 37
2021
Q1 		$9.16M Buy
+124,560
New +$9.19M 0.75% 42
2019
Q3 		– Sell
-504
Closed -$40K – 171
2019
Q2 		$40K Buy
+504
New +$38.6K ﹤0.01% 171
2018
Q3 		– Sell
-3,668
Closed -$212K – 199
2018
Q2 		$212K Buy
+3,668
New +$207K 0.02% 181

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cumberland Partners's MRK Position: Q2 2022 in Review

Cumberland Partners sold out of Merck (MRK) in Q2 2022, closing a stake of 93,360 shares — an estimated $7.66M sold.

Cumberland Partners first reported a position in MRK in Q2 2018 and held it in 7 quarters. The position peaked at $9.18M in Q2 2021. 3,014 funds tracked by Wall St. Rank hold MRK as of Q2 2022.

  • Cumberland Partners reported no remaining Merck position as of Q2 2022 after selling out during the quarter.
  • Cumberland Partners sold 93,360 Merck shares in Q2 2022, an estimated $7.66M.
  • Cumberland Partners first reported a position in Merck in Q2 2018 and held it in 7 quarters.
  • Cumberland Partners's Merck position peaked at $9.18M in Q2 2021.
  • 3,014 funds tracked by Wall St. Rank held Merck as of Q2 2022.

Based on Cumberland Partners's 13F filing for Q2 2022, filed 10 Aug 2022.